
Biosimilar Uptake Has Been Slow but This is Changing
Healthcare payers now have greater confidence in biosimilars and their ability to provide savings for plans and patients, James D. Chambers, Ph.D., M.Pharm., M.Sc., said in a recent interview. Chambers, who is a health economist at Tufts Medical Center and …